Lanthanum-based metal organic framework (La-MOF) use of 3,4-dihydroxycinnamic acid as drug delivery system linkers in human breast cancer therapy

Moosareza Safinejad, Amir Rigi, Malihe Zeraati, Zohreh Heidary, Shohreh Jahani, Narendra Pal Singh Chauhan, Ghasem Sargazi

Open source

DOI
10.1186/s13065-022-00886-y
Published
2022-11-12
Container
BMC Chemistry
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13065-022-00886-y,
  title = {Lanthanum-based metal organic framework (La-MOF) use of 3,4-dihydroxycinnamic acid as drug delivery system linkers in human breast cancer therapy},
  author = {Moosareza Safinejad and Amir Rigi and Malihe Zeraati and Zohreh Heidary and Shohreh Jahani and Narendra Pal Singh Chauhan and Ghasem Sargazi},
  year = {2022},
  journal = {BMC Chemistry},
  doi = {10.1186/s13065-022-00886-y},
  url = {https://doi.org/10.1186/s13065-022-00886-y}
}

RIS

TY  - JOUR
TI  - Lanthanum-based metal organic framework (La-MOF) use of 3,4-dihydroxycinnamic acid as drug delivery system linkers in human breast cancer therapy
AU  - Moosareza Safinejad
AU  - Amir Rigi
AU  - Malihe Zeraati
AU  - Zohreh Heidary
AU  - Shohreh Jahani
AU  - Narendra Pal Singh Chauhan
AU  - Ghasem Sargazi
PY  - 2022
JO  - BMC Chemistry
DO  - 10.1186/s13065-022-00886-y
UR  - https://doi.org/10.1186/s13065-022-00886-y
ER  - 

APA

Safinejad, M., Rigi, A., Zeraati, M., Heidary, Z., Jahani, S., Chauhan, N. P. S., & Sargazi, G. (2022). Lanthanum-based metal organic framework (La-MOF) use of 3,4-dihydroxycinnamic acid as drug delivery system linkers in human breast cancer therapy. BMC Chemistry. https://doi.org/10.1186/s13065-022-00886-y

Source records